These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 37562572)

  • 1. Review of Dohan Eherenfest et al. (2009) on "Classification of platelet concentrates: From pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF)".
    Marín Fermín T; Calcei JG; Della Vedova F; Martinez Cano JP; Arias Calderon C; Imam MA; Khoury M; Laupheimer MW; D'Hooghe P
    J ISAKOS; 2024 Apr; 9(2):215-220. PubMed ID: 37562572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In response to: Comment on "Review of Dohan Eherenfest et al. (2009) on "Classification of platelet concentrates: From pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF)".
    Marín Fermín T; Calcei JG; Della Vedova F; Martinez Cano JP; Arias Calderon C; Imam MA; Khoury M; Laupheimer MW; D'hooghe P
    J ISAKOS; 2024 Feb; 9(1):89-90. PubMed ID: 37806660
    [No Abstract]   [Full Text] [Related]  

  • 3. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF).
    Dohan Ehrenfest DM; Rasmusson L; Albrektsson T
    Trends Biotechnol; 2009 Mar; 27(3):158-67. PubMed ID: 19187989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comment on "Review of Dohan Eherenfest et al. (2009) on classification of platelet concentrates: From pure platelet-rich plasma (p-prp) to leucocyte- and platelet-rich fibrin (l-prf)".
    Sánchez M; Delgado D; Espregueira-Mendes J
    J ISAKOS; 2024 Feb; 9(1):91-92. PubMed ID: 37806658
    [No Abstract]   [Full Text] [Related]  

  • 5. The impact of the centrifuge characteristics and centrifugation protocols on the cells, growth factors, and fibrin architecture of a leukocyte- and platelet-rich fibrin (L-PRF) clot and membrane.
    Dohan Ehrenfest DM; Pinto NR; Pereda A; Jiménez P; Corso MD; Kang BS; Nally M; Lanata N; Wang HL; Quirynen M
    Platelets; 2018 Mar; 29(2):171-184. PubMed ID: 28437133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-rich concentrates differentially release growth factors and induce cell migration in vitro.
    Schär MO; Diaz-Romero J; Kohl S; Zumstein MA; Nesic D
    Clin Orthop Relat Res; 2015 May; 473(5):1635-43. PubMed ID: 25690170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In search of a consensus terminology in the field of platelet concentrates for surgical use: platelet-rich plasma (PRP), platelet-rich fibrin (PRF), fibrin gel polymerization and leukocytes.
    Dohan Ehrenfest DM; Bielecki T; Mishra A; Borzini P; Inchingolo F; Sammartino G; Rasmusson L; Everts PA
    Curr Pharm Biotechnol; 2012 Jun; 13(7):1131-7. PubMed ID: 21740379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous platelet concentrates in maxillofacial regenerative therapy.
    Chou TM; Chang HP; Wang JC
    Kaohsiung J Med Sci; 2020 May; 36(5):305-310. PubMed ID: 32052598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do the fibrin architecture and leukocyte content influence the growth factor release of platelet concentrates? An evidence-based answer comparing a pure platelet-rich plasma (P-PRP) gel and a leukocyte- and platelet-rich fibrin (L-PRF).
    Dohan Ehrenfest DM; Bielecki T; Jimbo R; Barbé G; Del Corso M; Inchingolo F; Sammartino G
    Curr Pharm Biotechnol; 2012 Jun; 13(7):1145-52. PubMed ID: 21740377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in separation methods for the use of platelet-rich fibrin in tissue repair: an integrative review.
    Dos Santos RF; Araújo Peres JA; Queiroz MS
    Gen Dent; 2023; 71(2):65-69. PubMed ID: 36825976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current knowledge and perspectives for the use of platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) in oral and maxillofacial surgery part 2: Bone graft, implant and reconstructive surgery.
    Simonpieri A; Del Corso M; Vervelle A; Jimbo R; Inchingolo F; Sammartino G; Dohan Ehrenfest DM
    Curr Pharm Biotechnol; 2012 Jun; 13(7):1231-56. PubMed ID: 21740370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of incubation method on the release of growth factors in non-Ca
    Steller D; Herbst N; Pries R; Juhl D; Hakim SG
    J Craniomaxillofac Surg; 2019 Feb; 47(2):365-372. PubMed ID: 30578012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative release of growth factors from PRP, PRF, and advanced-PRF.
    Kobayashi E; Flückiger L; Fujioka-Kobayashi M; Sawada K; Sculean A; Schaller B; Miron RJ
    Clin Oral Investig; 2016 Dec; 20(9):2353-2360. PubMed ID: 26809431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of an injectable platelet-rich fibrin on osteoblast behavior and bone tissue formation in comparison to platelet-rich plasma.
    Wang X; Zhang Y; Choukroun J; Ghanaati S; Miron RJ
    Platelets; 2018 Jan; 29(1):48-55. PubMed ID: 28351189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classification of platelet concentrates (Platelet-Rich Plasma-PRP, Platelet-Rich Fibrin-PRF) for topical and infiltrative use in orthopedic and sports medicine: current consensus, clinical implications and perspectives.
    Dohan Ehrenfest DM; Andia I; Zumstein MA; Zhang CQ; Pinto NR; Bielecki T
    Muscles Ligaments Tendons J; 2014 Jan; 4(1):3-9. PubMed ID: 24932440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Injectable-platelet rich fibrin using the low speed centrifugation concept improves cartilage regeneration when compared to platelet-rich plasma.
    Abd El Raouf M; Wang X; Miusi S; Chai J; Mohamed AbdEl-Aal AB; Nefissa Helmy MM; Ghanaati S; Choukroun J; Choukroun E; Zhang Y; Miron RJ
    Platelets; 2019; 30(2):213-221. PubMed ID: 29240523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Liquid Platelet-rich Fibrin and Platelet-rich Plasma on the Regenerative Potential of Dental Pulp Cells Cultured under Inflammatory Conditions: A Comparative Analysis.
    Chai J; Jin R; Yuan G; Kanter V; Miron RJ; Zhang Y
    J Endod; 2019 Aug; 45(8):1000-1008. PubMed ID: 31248700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current knowledge and perspectives for the use of platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) in oral and maxillofacial surgery part 1: Periodontal and dentoalveolar surgery.
    Del Corso M; Vervelle A; Simonpieri A; Jimbo R; Inchingolo F; Sammartino G; Dohan Ehrenfest DM
    Curr Pharm Biotechnol; 2012 Jun; 13(7):1207-30. PubMed ID: 21740371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shedding light in the controversial terminology for platelet-rich products: platelet-rich plasma (PRP), platelet-rich fibrin (PRF), platelet-leukocyte gel (PLG), preparation rich in growth factors (PRGF), classification and commercialism.
    Dohan Ehrenfest DM; Bielecki T; Del Corso M; Inchingolo F; Sammartino G
    J Biomed Mater Res A; 2010 Dec; 95(4):1280-2. PubMed ID: 20925082
    [No Abstract]   [Full Text] [Related]  

  • 20. Microbicidal properties of Leukocyte- and Platelet-Rich Plasma/Fibrin (L-PRP/L-PRF): new perspectives.
    Cieslik-Bielecka A; Dohan Ehrenfest DM; Lubkowska A; Bielecki T
    J Biol Regul Homeost Agents; 2012; 26(2 Suppl 1):43S-52S. PubMed ID: 23648198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.